CannaPharmaRX (CPMD) Stock Price, News & Analysis

Company Overview

CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

Key Stats

• Today's Range: $0.0084 to $0.0084
• 50-Day Range: $0.0030 to $0.01
• 52-Week Range: $0.00 to $0.03
• Volume: N/A
• Average Volume: 76,587 shs
• Market Capitalization: $5.55 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CPMD Stock Analysis - Frequently Asked Questions

How have CPMD shares performed this year?

CannaPharmaRX's stock was trading at $0.0081 on January 1st, 2025. Since then, CPMD shares have increased by 3.7% and is now trading at $0.0084.
View the best growth stocks for 2025 here.

How do I buy shares of CannaPharmaRX?

Shares of CPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of CannaPharmaRX own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CannaPharmaRX investors own include FuelCell Energy (FCEL), Blackstone (BX), Global Helium (HECOF), Trillium Therapeutics (TRIL), Block (SQ), AFC Gamma (AFCG) and American Lithium (AMLI).

Company Calendar

• Today: 1/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CPMD
• CUSIP: N/A
• CIK: 1081938
• Web: www.cannapharmarx.com
• Phone: (949) 652-6838
• Fax: 720-875-1905
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $3.69 million
• Net Margins: N/A
• Pretax Margin: 408.11%
• Return on Equity: N/A
• Return on Assets: -41.99%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.07
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.03) per share
• Price / Book: -0.28

Miscellaneous

• Outstanding Shares: 660,630,000
• Free Float: 652,236,000
• Market Cap: $5.55 million
• Optionable: Not Optionable
• Beta: 2.36